Zhuang, G, Schmidt, M, Yao, J, Wu, X, Kaminker, JS, Jurinka, SS, Kolumam, G, Chung, AS, Jubb, A, Modrusan, Z, Ozawa, T, James, CD, Phillips, H, Haley, B, Tam, RNW, Clermont, AC, Cheng, JH, Yang, SX, Swain, SM, Chen, D, Scherer, SJ, Koeppen, H, Yeh, RF, Yue, P, Stephan, JP, Hegde, P, Ferrara, N, Singh, M and Bais, C (2013) Identification and Analysis of In Vivo VEGF Downstream Markers Link VEGF Pathway Activity with Efficacy of Anti-VEGF Therapies. CLINICAL CANCER RESEARCH. pp. 3681-3692.

Item Type:	Article
Additional Information:	pubid: 115 nvp_institute: NIBR contributor_address: Genentech Inc, San Francisco, CA 94131 USA mallika.singh@novartis.com; Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA, Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA USA ; NCI, NIH, Div Canc Treatment & Diag, Nat Clin Target Validat Lab, Bethesda, MD USA ; Medstar Washington Hosp, Washington Canc Inst, Washington, DC USA ; Novartis Inst Biomed Res, Emeryville, CA USA ; Genentech Inc, San Francisco, CA 94131 USA; Bais, C; Genentech Inc, 1 DNA Way, San Francisco, CA 94131 USA
Date Deposited:	13 Oct 2015 13:13
Last Modified:	13 Oct 2015 13:13
URI:	https://oak.novartis.com/id/eprint/21953